Novan to Report Third Quarter 2021 Financial Results on November 10, 2021
03 Novembro 2021 - 10:00AM
Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today
announced that it will report its third quarter 2021 financial
results on Wednesday, November 10th. Novan management will host a
conference call and live audio webcast to discuss the operational
and financial results at 8:30 a.m. ET that same day.
The call will be led by Paula Brown Stafford,
President and Chief Executive Officer of Novan, who will be joined
by additional members of the Novan management team. Interested
participants and investors may access the conference call by
dialing (844) 707-0661 (domestic) or (703) 318-2240 (international)
and referencing conference ID: 1142988. The live webcast will be
accessible on the Events page of the Investors section of the Novan
website, novan.com, and will be archived for 90 days.
About Novan
Novan, Inc. is a pre-commercial nitric
oxide-based pharmaceutical company focused on dermatology and
anti-infective therapies. We leverage our core synergies of
science, capital, resources and patient needs to create value by
bringing new nitric oxide-based medicines to market. Our goal is to
create the world’s leader in nitric oxide-based science,
technology, and clinical translation in support of delivering safe
and efficacious therapies using our proprietary nitric oxide-based
technology platform, NITRICIL™ to generate macromolecular New
Chemical Entities (NCEs) to treat multiple indications.
INVESTOR AND MEDIA CONTACT:
Jenene Thomas JTC Team,
LLC833-475-8247NOVN@jtcir.com
Novan (NASDAQ:NOVN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Novan (NASDAQ:NOVN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024